Related Experiment Video
Updated: Apr 14, 2026

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
Published on: January 27, 2023
ERK5 activation is essential for osteoclast differentiation
Shigeru Amano1, Yu-Tzu Chang2, Yasuhisa Fukui2
1Division of Microbiology and Immunology, Department of Oral Biology and Tissue Engineering, Meikai University School of Dentistry, Keyakidai, Sakado City, Japan.
Abstract:
The MEK/ERK pathways are critical for controlling cell proliferation and differentiation. In this study, we show that the MEK5/ERK5 pathway participates in osteoclast differentiation. ERK5 was activated by M-CSF, which is one of the essential factors in osteoclast differentiation. Inhibition of MEK5 by BIX02189 or inhibition of ERK5 by XMD 8-92 blocked osteoclast differentiation. MEK5 knockdown inhibited osteoclast differentiation. RAW264.7D clone cells, which are monocytic cells, differentiate into osteoclasts after stimulation with sRANKL. ERK5 was activated without any stimulation in these cells. Inhibition of the MEK5/ERK5 pathway by the inhibitors also blocked the differentiation of RAW264.7D cells into osteoclasts. Moreover, expression of the transcription factor c-Fos, which is indispensable for osteoclast differentiation, was inhibited by treatment with MEK5 or ERK5 inhibitors. Therefore, activation of ERK5 is required for the induction of c-Fos. These events were confirmed in experiments using M-CSF-dependent bone marrow macrophages. Taken together, the present results show that activation of the MEK5/ERK5 pathway with M-CSF is required for osteoclast differentiation, which may induce differentiation through the induction of c-Fos.
Insights
The MEK5/ERK5 pathway is essential for osteoclast differentiation, activated by M-CSF. Inhibiting this pathway blocks differentiation by preventing c-Fos induction, crucial for bone cell development.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathways regulate cell proliferation and differentiation.
- Osteoclast differentiation is a complex process involving specific signaling pathways and transcription factors.
Purpose of the Study:
- To investigate the role of the MEK5/ERK5 pathway in osteoclast differentiation.
- To determine if MEK5/ERK5 signaling is required for the induction of key transcription factors involved in osteoclastogenesis.
Main Methods:
- Utilized specific inhibitors (BIX02189 for MEK5, XMD 8-92 for ERK5) and knockdown techniques to block MEK5/ERK5 signaling.
- Examined osteoclast differentiation in RAW264.7D cells and primary M-CSF-dependent bone marrow macrophages.
- Assessed the expression of the transcription factor c-Fos.
Main Results:
- Activation of ERK5 by M-CSF was observed, a key factor in osteoclast differentiation.
- Inhibition or knockdown of MEK5/ERK5 significantly blocked osteoclast differentiation in both cell lines.
- MEK5/ERK5 inhibition reduced the expression of c-Fos, indicating its necessity for c-Fos induction.
Conclusions:
- The MEK5/ERK5 pathway is critically involved in M-CSF-induced osteoclast differentiation.
- Activation of ERK5 is required for the induction of c-Fos, a transcription factor essential for osteoclastogenesis.
- Targeting the MEK5/ERK5 pathway offers a potential strategy for modulating osteoclast differentiation.
Related Concept Videos
Osteoclasts in Bone Remodeling
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Bone Remodeling
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...
TGF - β Signaling Pathway
Differentiation of Common Myeloid Progenitor Cells

